Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) shares dropped 7.4% on Wednesday . The stock traded as low as $0.19 and last traded at $0.22. Approximately 103,096 shares traded hands during trading, an increase of 412% from the average daily volume of 20,150 shares. The stock had previously closed at $0.24.
Alpha Tau Medical Stock Down 15.0 %
The stock’s fifty day moving average price is $0.28 and its 200-day moving average price is $0.24.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Featured Stories
- Five stocks we like better than Alpha Tau Medical
- 3 Healthcare Dividend Stocks to Buy
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Invest in Small Cap Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Transportation Stocks Investing
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
